-
Staff Photo by Dan Henry Minnnied Hyter, left, and Cassandra Lee watch for label quality as bottles of Selsun Blue pass by at the Chattem plant.
Sanofi-Aventis has completed its acquisition of Chattanooga-based Chattem Inc., which now becomes the French company’s consumer health care division in the United States.
The 130-year-old Chattem agreed late last year to be bought for $1.9 billion in cash by Sanofi-Aventis, the maker of pharmaceuticals such as antihistamine Allegra and heart medicine Plavix.
According to Paris-based Sanofi-Aventis, the acquisition provides new channels for maximizing the potential of converting its prescription medicines to over-the-counter products, beginning with Allegra.
Also, the company said it expects to obtain significant revenue synergies through the expansion of Chattem’s products into currently untapped geographic markets where Sanofi-Aventis has a strong operating presence.
Continue reading by following these links to related stories:
Article: Sanofi finishes tender offer
Article: Chattem profits rise 25% in quarter
Mike Pare, the deputy Business editor at the Chattanooga Times Free Press, has worked at the paper for 27 years. In addition to editing, Mike also writes Business stories and covers Volkswagen, economic development and manufacturing in Chattanooga and the surrounding area. In the past he also has covered higher education. Mike, a native of Fort Lauderdale, Fla., received a bachelor’s degree in communications from Florida Atlantic University. he worked at the Rome News-Tribune before ...
Or login with:
New Account